|
Online Database of Chemicals from Around the World | Search | Submit | Advertise |
Home >> Chemical Listing >> Mipomersen>> Market Analysis Reports |
Market Analysis Reports of Mipomersen |
|
Isis Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis ... and Development Cardiovascular Franchise Mipomersen Mipomersen is an apolipoprotein B (apoB) synthesis ... 2008, the company licensed mipomersen to Genzyme Corporation as part of a ... transaction to develop and commercialize mipomersen. ISIS-CRPRx ISIS-CRPRx ... Dyslipidaemia: KOL Insight ... ? Do KOLs expect it to come down? Kynamro (mipomersen; Sanofi): What factors will determine ... Global Pharmaceutical & Biotechnology Outlook 2013: Global Pharma Over the next five years, we will witness surge in approval of new drugs that would deliver a major improvement in the standard of care. Therapy areas - Oncology, Diabetes, Ophthalmology HCV, Atrial Fibrillation, Multiple Sclerosis, Dyslipidemia, Alzheimer ... Hyperlipidemia Drugs Market Analysis Report by Drug Class (Statins, PCSK9 Inhibitors, Bile Acid Sequestrants, Cholesterol Absorption Inhibitors, Fibric Acid Derivatives, Combination), and Segment Forecasts, 2016 - 2022 ... existing expensive therapies, lomitapide, and mipomersen for the treatment of homozygous FH patients ... Intracranial Arterial Diseases - Pipeline Review - 2019 ... List of products Darapladib, Dalcetrapib (RG1658), Mipomersen (ISIS 301012), Vorapaxar (SCH 530348 ... RNAi Drug Delivery: Technologies and Global Markets Report Scope: This research report categorizes the market for nucleic acid drugs by type. The major product segments are conjugated and encapsulated. The non-viral vectors used for encapsulation are divided into polymers, lipids and others (e.g., inorganic ... LDL-C Lowering Therapeutics Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Product Type ... : statins ezetimibe bempedoic acid lomitapide mipomersen and icosapent ethyl Others Companies ... Oligonucleotide Therapeutic Drugs Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Product Type ... Market Share Types Segment: fomivirsen mipomersen inotersen eteplirsen golodirsen nusinersen patisiran ... Cardiovascular Risk Reduction Therapeutics Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Product Type ... : statins ezetimibe bempedoic acid lomitapide mipomersen and icosapent ethyl Others Companies ... LDL-C Lowering Therapeutics Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Product Type ... : statins ezetimibe bempedoic acid lomitapide mipomersen and icosapent ethyl Others Companies ... Oligonucleotide Therapeutic Drugs Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Product Type ... Market Share Types Segment: fomivirsen mipomersen inotersen eteplirsen golodirsen nusinersen patisiran ... SANOFI - 4Q Results - No Surprises, Growth going forward will be Challenging ... for Teriflunomide (Multiple Sclerosis – €150m), Mipomersen (hypercholesterolemia- €150m), Aflibercept (colorectal cancer ... ISIS Pharma - Picture Beyond KYNAMRO - Targeting Other Niche Indications Approval of KYNAMRO (mipomersen, apoB synthesis inhibitor, homozygous – HoFH; ... |